盈健医疗2026财年中期营收3.424亿港元,经调整净利润1,830万港元

公告速递
Feb 26

本季度信息

盈健医疗集团截至2025年12月31日止2026财年中期录得营收约3.424亿港元,同比上升8.4%。经调整净利润(基于公告中的本公司拥有人应占溢利数据)约1,830万港元,同比增加8.5%。报告期内毛利约1.595亿港元,对应毛利率约46.6%,上一年同期为47.1%。行政及其他开支有所上升,同期相比增加约6.3百万港元。

业务分项

在全科医疗服务方面,营收约2.139亿港元,同比上升3.5%,主要受病人就诊次数稳步增长驱动。专科医疗服务营收为8,166万港元,同比微增0.5%。牙科服务收入达4,677万港元,同比大幅增长67.5%,其中除现有业务稳健表现外,祐德牙科的合并也带来显著贡献。分项毛利率方面,全科医疗服务毛利率为53.0%,专科医疗服务为31.5%,牙科服务则为43.7%。

高管解读

(无相关原话披露,故不显示)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10